• Facebook
• Twitter
• Flipboard
• Comments
• Print
• Email

New Alzheimer's drug pending FDA approval

Chief Washington correspondent Mike Emanuel reports the latest on the new Alzheimer's drug.

A great deal of emphasis is placed on the emotional and mental impact of dementia — but a new study from the University of Michiganhighlights the financial burden it puts on families as well.